The company will not receive any proceeds from the sale of the common shares by the selling shareholders.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NLSP:
- NLS Pharmaceutics Strikes Debt Forgiveness Deal
- NLS Pharmaceutics secures patent in Japan for Mazindol ER
- NLS Pharmaceutics Sees Reduced Losses Amid Financial Challenges
- NLS Pharmaceutics Boosts Financial Standing with Key Moves
- NLS Pharmaceutics announces expected compliance with Nasdaq listing rules